9 METERS BIOPHARMA, INC. Quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD from Q4 2015 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
9 Meters Biopharma, Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q4 2015 to Q4 2022.
  • 9 Meters Biopharma, Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending December 31, 2022 was $21.4M, a 14.8% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $21.4M +$2.76M +14.8% Dec 31, 2022 10-K 2023-03-28
Q4 2021 $18.7M +$4.86M +35.2% Dec 31, 2021 10-K 2023-03-28
Q4 2020 $13.8M +$3.94M +40% Dec 31, 2020 10-K 2022-03-23
Q4 2019 $9.86M +$5.52M +127% Dec 31, 2019 10-K 2021-03-22
Q4 2018 $4.34M +$3.47M +401% Dec 31, 2018 10-K 2020-03-20
Q4 2017 $866K -$10.6M -92.5% Dec 31, 2017 10-K 2019-03-18
Q4 2016 $11.5M +$2.41M +26.6% Dec 31, 2016 10-K 2018-03-14
Q4 2015 $9.06M Dec 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.